𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Microdeletions involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patients

✍ Scribed by Arvid Suls; Kristl G. Claeys; Dirk Goossens; Boris Harding; Rob Van Luijk; Stefaan Scheers; Liesbet Deprez; Dominique Audenaert; Tine Van Dyck; Sabine Beeckmans; Iris Smouts; Berten Ceulemans; Lieven Lagae; Gunnar Buyse; Nina Barisic; Jean-Paul Misson; Jan Wauters; Jurgen Del-Favero; Peter De Jonghe; Lieve R.F. Claes


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
329 KB
Volume
27
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Severe myoclonic epilepsy of infancy (SMEI) or Dravet syndrome is a rare epilepsy syndrome. In 30 to 70% of SMEI patients, truncating and missense mutations in the neuronal voltage-gated sodium-channel alpha-subunit gene (SCN1A) have been identified. The majority of patients have truncating mutations that are predicted to be loss-of-function alleles. Because mutation detection studies use PCR-based sequencing or conformation sensitive gel electrophoresis (CSGE), microdeletions, which are also predicted to be loss-of-function alleles, can easily escape detection. We selected 11 SMEI patients with or without additional features who had no SCN1A mutation detectable with sequencing analysis. In addition, none of the patients was heterozygous for any of the SNPs in SCN1A, indicating that they were either homozygous for all SNPs or hemizygous due to a microdeletion of the gene. We subsequently analyzed these patients for the presence of microdeletions in SCN1A using a quantitative PCR method named multiplex amplicon quantification (MAQ), and observed three patients missing one copy of the SCN1A gene. All three microdeletions were confirmed by fluorescence in situ hybridization (FISH). These findings demonstrate that a substantial percentage of SCN1A-mutation-negative SMEI patients with or without additional features carry a chromosomal microdeletion comprising the SCN1A gene and that haploinsufficiency of the SCN1A gene is a cause of SMEI.


πŸ“œ SIMILAR VOLUMES


Mosaicism for the full mutation and a mi
✍ Grasso, M.; Faravelli, F.; Nigro, C. Lo; Chiurazzi, P.; Sperandeo, M.P.; Argusti πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 32 KB πŸ‘ 2 views

The molecular mechanism of the fragile X syndrome is based on the expansion of an unstable CGG repeat in the 5 untranslated region of the FMR1 gene in most patients. This expansion is associated with an abnormal DNA methylation leading to the absence of production of FMR1 protein (FMRP). Such expans

The novel p.L1649Q mutation in the SCN1A
✍ Kaate R.J. Vanmolkot; Elena Babini; Boukje de Vries; Anine H. Stam; Tobias Freil πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 492 KB

Familial hemiplegic migraine (FHM) is a severe subtype of migraine with hemiparesis during attacks. We scanned 10 families with FHM without mutations in the CACNA1A (FHM1) and ATP1A2 (FHM2) genes. We identified the novel p.L1649Q mutation (c.4946T>A) in Na(v)1.1 sodium channel gene SCN1A (FHM3) in a

Twenty-one novel mutations in the GLB1 g
✍ RaΓΌl Santamaria; Amparo ChabΓ‘s; Maria Josep Coll; Clara Sa Miranda; LluΓ―sa Vilag πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 174 KB πŸ‘ 1 views

## Communicated by Elizabeth Neufeld GM1-gangliosidosis and Morquio B disease are rare lysosomal storage disorders caused by Ξ²-galactosidase deficiency due to mutations in the GLB1 gene. Three major clinical forms of GM1-gangliosidosis have been established on the basis of age of onset and severit